chr16-54284851-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_024336.3(IRX3):c.1030C>A(p.Leu344Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,543,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024336.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRX3 | NM_024336.3 | c.1030C>A | p.Leu344Met | missense_variant | 2/4 | ENST00000329734.4 | NP_077312.2 | |
IRX3 | XM_005256139.4 | c.1030C>A | p.Leu344Met | missense_variant | 2/4 | XP_005256196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRX3 | ENST00000329734.4 | c.1030C>A | p.Leu344Met | missense_variant | 2/4 | 1 | NM_024336.3 | ENSP00000331608.3 | ||
IRX3 | ENST00000558054.1 | c.73-539C>A | intron_variant | 2 | ENSP00000463991.1 | |||||
IRX3 | ENST00000558180.2 | n.809C>A | non_coding_transcript_exon_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152144Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000101 AC: 14AN: 1391492Hom.: 0 Cov.: 40 AF XY: 0.00000729 AC XY: 5AN XY: 686134
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.1030C>A (p.L344M) alteration is located in exon 2 (coding exon 2) of the IRX3 gene. This alteration results from a C to A substitution at nucleotide position 1030, causing the leucine (L) at amino acid position 344 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at